CDC42 and breast carcinoma: The western blot results showed that miR-29a has a negative regulatory role regarding Cdc42 expression in MIN6 cells, which is similar to the findings for cancers such as nonsmall-cell carcinoma, stomach cancer, and breast cancer [42, 43, 57].